Quest Laboratories logo

Quest Laboratories financials and balance sheet

NSE: QUESTLABPharmaceuticals & Biotechnology

Last close ₹82.00down ₹5.40 (6.18%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹87.40.

52-week range of traded prices to 23 Oct 2026
₹68.60Low, 21 Sep 2026₹152.60High, 30 Apr 2026
Market cap
₹134 Cr
P/E
No recent results
P/B
No recent results
Dividend yield
Nonein the last 12 months
Volume, NSE
12,000

3 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Quest Laboratories annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹112 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue112
  2. Materials and goods−86
  3. Employee costs−4.8
  4. Other expenses−2.5
  5. Operating profit18
  6. Depreciation−0.8
  7. Other income+2.5
  8. One-off items0.0
  9. Finance costs−1.9
  10. Profit before tax18
  11. Tax−3.1
  12. Net profit15

What the company owns

  • Inventory₹39 Cr
  • Receivables₹36 Cr
  • Plant, investments and other assets₹24 Cr
  • Current investments₹12 Cr
  • Cash and bank₹0 Cr

What pays for it: net worth and liabilities

  • Net worth₹97 Cr
  • Borrowings₹8 Cr
  • Owed to suppliers₹6 Cr
  • Other liabilities₹1 Cr

Profit and loss

Standalone, ₹ crore, years to March.Quest Laboratories quarterly results

₹ croreMar 2024Mar 2025Filed 28 MayMar 2026Filed 29 May
Revenue from operations83104112
678894
Materials and goods bought527986
Employee costs445
Other expenses1042
Operating profit before depreciation161618
Operating margin18.8%15.4%16.3%
Materials, % of revenue63.3%76.2%77.2%
Employee costs, % of revenue5.2%4.1%4.3%
Other expenses, % of revenue12.7%4.3%2.2%
Depreciation and amortisation111
Operating profit after depreciation151517
Other income043
Finance costs112
One-off items000
Profit before tax141918
453
Net profit101415
Net margin12.2%13.1%13.4%

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2025Filed 28 MayMar 2026Filed 29 May
8297
Share capital1616
Reserves6580
308
3713
32
Total assets122111
1520
10792
Net debt−19−4
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the year to Mar 2024, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2025Filed 28 MayMar 2026Filed 29 May
−23.5−10.7
−16.4−3.9
−32.4−23.1
Receivables−6.6−6.2
Inventories−5.2−17.3
Payables−17.3−0.1
Other working capital−3.20.5
Tax paid−4.1−4.6
Capital spending3.55.3
Free cash flow−26.9−16.0
−44.034.9
67.4−24.2
Dividends paid0.00.0
Shares bought back0.00.0
Shares issued43.20.0
Net change in cash0.00.0
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the year to Mar 2024.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2025Filed 28 MayMar 2026Filed 29 May
Earnings per share₹8.28₹9.16
Diluted earnings per share₹8.28₹9.16
Book value per share₹49.92₹59.08
Shareholder yield−25.7%0.0%
Market cap at the year end (₹ crore)168171

Ratios

Standalone, years to March.Quest Laboratories PE ratio and valuation

RatioMar 2024Mar 2025Filed 28 MayMar 2026Filed 29 May
Revenue growth–25.9%7.6%
Operating profit growth–2.8%14.2%
Net profit growth–34.4%10.7%
Earnings per share growth––10.6%
–16.6%16.8%
––0.2 pts
From the net margin––0.5 pts
From asset turnover––2.1 pts
From borrowing––−2.4 pts
Return on capital employed–13.7%16.6%
Cash conversion–−173.1%−71.4%
Interest cover19.616.99.4
Debt to equity–0.370.08
Receivable days–105118
Inventory days–99163
Payable days–2624
Cash conversion cycle, days–178258
Working capital days–173241
Asset turnover–0.850.96
Assets per rupee of net worth–1.491.30
Sales per rupee of plant–8.827.55
Capital spending to depreciation–5.466.37
Plant being built, % of plant in use–0.0%9.9%
No balance sheet is on record for the year to Mar 2024, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
12.9%
Cash from operations against operating profit
−58.7%
Measure3 years
Return on equity, average16.7%
Return on capital employed, average15.2%
Operating margin, average16.8%
Net margin, average12.9%
Asset turnover, average0.91
Cash conversion cycle, days, average218
Interest cover, average15.3
Debt to equity, average0.23

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations−10.7
Cash from investing34.9
Cash from financing−24.2
Capital spending5.3
Dividends paid0.0
Shares bought back0.0
Shares issued for cash0.0
Borrowings repaid0.0

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2024Mar 2025Mar 2026
Altman Z-scorePublished threshold 1.81–5.3510.63
Beneish M-scorePublished threshold −1.78––−0.62
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––−7.91
Receivables growth less revenue growthOur threshold 0 percentage points––12.98
Inventory growth less cost-of-goods growthOur threshold 0 percentage points––71.67
Other current assets growth less revenue growthOur threshold 5 per cent of revenue––−1.59
Assets under construction, years of additionsOur threshold 2 years of additions––0.38
Effective tax ratePublished threshold 17.16 per cent30.1327.3917.06
Tax charged less tax paid, % of profitOur threshold 10 percentage points–5.53−8.22
A threshold marked as ours has no published figure; it is the line we read the check against.